Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Intrathecal Chemotherapy Prophylaxis for CNS Relapse of DLBCL In the RCHOP Era: A Single Center Analysis.

Christopher Scott Kovacs, Jr., MD, John William Sweetenham, MD, FRCP, Marc Earl, Pharm., D., R.Ph., Robert Dean, MD, Brad Pohlman, MD, Brian Bolwell, MD, Stephen D. Smith, MD, BS

Blood (2010) 116 (21): 2804.

https://doi.org/10.1182/blood.V116.21.2804.2804

Published: 2010

Journal Articles

High Rate of Survival in Transformed Lymphoma after Autologous Stem Cell Transplant (ASCT): Pathologic Analysis and Comparison with De Novo DLBCL.

Stephen S. Smith, MD, Brian Bolwell, MD, Anjali Advani, MD, Steven Andresen, DO, Josephine Chan, Robert Dean, MD, Eric Hsi, MD, Matt Kalaycio, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Ronald Sobecks, MD, John Sweetenham, MD

Blood (2008) 112 (11): 1137.

https://doi.org/10.1182/blood.V112.11.1137.1137

Published: 2008

Journal Articles

Impact on Pulmonary Function of Pre-Transplant Radiotherapy in Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant (ASCT).

Christy Stotler, DO, Paul Elson, ScD, Brian Bolwell, MD, Matt Kalaycio, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Robert Dean, MD, Steven Andresen, DO, Edward Copelan, MD, Josephine Chan, John Sweetenham, MD

Blood (2008) 112 (11): 3279.

https://doi.org/10.1182/blood.V112.11.3279.3279

Published: 2008

Journal Articles

Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation.

Edward Copelan, MD, Ronald Sobecks, MD, Robert Dean, MD, Lisa Rybicki, Stacey Brown, Matt Kalaycio, MD, Brad Pohlman, MD, John William Sweetenham, MD, Steven Andresen, DO, Brian Bolwell, MD

Blood (2007) 110 (11): 5003.

https://doi.org/10.1182/blood.V110.11.5003.5003

Published: 2007

Journal Articles

Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation.

Anuj Mahindra, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Robert Dean, MD, Steve Andresen, DO, Matt Kalaycio, MD, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1109.

https://doi.org/10.1182/blood.V110.11.1109.1109

Published: 2007

Journal Articles

Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant.

Anuj Mahindra, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Matt Kalaycio, MD, Robert Dean, MD, Steve Andresen, DO, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 2882.

https://doi.org/10.1182/blood.V110.11.2882.2882

Published: 2007

Journal Articles

Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.

Anuj Mahindra, MD, Ronald Sobecks, MD, Lisa Rybicki, MS, Stacey Brown, Brad Pohlman, MD, Matt Kalaycio, MD, Robert Dean, MD, Steve Andresen, DO, John Sweetenham, MD, Brian Bolwell, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1986.

https://doi.org/10.1182/blood.V110.11.1986.1986

Published: 2007

Journal Articles

Long Term Follow Up with Etoposide Priming in Patients with Lymphoma.

Anuj Mahindra, MD, Brian Bolwell, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Stacey Brown, Robert Dean, MD, Matt Kalaycio, MD, Steve Andresen, DO, Ronald Sobecks, MD, John Sweetenham, MD, Edward Copelan, MD

Blood (2007) 110 (11): 1895.

https://doi.org/10.1182/blood.V110.11.1895.1895

Published: 2007

Journal Articles

Elevated Pretransplant Serum Ferritin in Autologous Stem Cell Transplant.

Blood (2007) 110 (11): 606.

https://doi.org/10.1182/blood.V110.11.606.606

Published: 2007

Journal Articles

Pre-Transplant Biomarkers Predict GVHD and Treatment-Related Mortality in Patients Treated with Extracorporeal Photopheresis Prior to Allogeneic Bone Marrow Transplantation.

Peter J. O’Brien, PhD, Brian Bolwell, MD, Sunil Abhyankar, MD, Paul Shaughnessy, MD, Koen van Besien, MD, Paul Williamson, MD, Kim A. Campbell, PhD

Blood (2006) 108 (11): 5182.

https://doi.org/10.1182/blood.V108.11.5182.5182

Published: 2006

Journal Articles

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Anjali S. Advani, MD, Sarah Gibson, MD, Tao Jin, MS, Ramon Tiu, MD, Giridharan Ramsingh, MD, Matt Kalaycio, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Shawnda Sungren, BBA, Eric D. Hsi, MD

Blood (2006) 108 (11): 1846.

https://doi.org/10.1182/blood.V108.11.1846.1846

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Brian Bolwell, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Stacey Brown, Jennifer Bates, Lisa Rybicki, Julie Curtis, R.N., Kimberly Bell, R.N., Ronald M. Sobecks, MD

Blood (2005) 106 (11): 2083.

https://doi.org/10.1182/blood.V106.11.2083.2083

Published: 2005

Journal Articles

Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML).

Matt Kalaycio, MD, Mikkael Sekeres, MD, Ronald Sobecks, MD, Lisa Rybicki, Brad Pohlman, MD, Anjali Advani, MD, Elizabeth Kuczkowski, Brian Bolwell, MD

Blood (2005) 106 (11): 4500.

https://doi.org/10.1182/blood.V106.11.4500.4500

Published: 2005

Journal Articles

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Brian Bolwell, MD, Lisa Rybicki, Matt Kalaycio, MD, Brad Pohlman, MD, Steven Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Ronald Sobecks, MD

Blood (2005) 106 (11): 3667.

https://doi.org/10.1182/blood.V106.11.3667.3667

Published: 2005

Journal Articles

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Ronald M. Sobecks, MD, Karl S. Theil, MD, Lisa Rybicki, Roger Macklis, MD, Brad Pohlman, MD, Steve Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Kelly Cherni, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Matt Kalaycio, MD, Brian Bolwell, MD

Blood (2005) 106 (11): 3674.

https://doi.org/10.1182/blood.V106.11.3674.3674

Published: 2005

Journal Articles

Severe Mucositis Adversely Affects Survival after Autologous Stem Cell Transplantation (ABMT) for Lymphoid Malignancies.

Brian Bolwell, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Steven Andresen, DO, Lisa Rybicki, Elizabeth Kuczkowski, Sherry Mendiola, Joe Kohuth, Kimberly Bell, R.N., Julie Curtis, R.N., Stacey Brown, Brad Pohlman, MD

Blood (2005) 106 (11): 837.

https://doi.org/10.1182/blood.V106.11.837.837

Published: 2005

Journal Articles

Molecular Identification of Alloreactive CTL Precursors in Hematopoietic Stem Cell Transplantation.

Christine O’Keefe, PhD, Lukasz Gondek, MD, Ronald Sobecks, MD, Alexander Rodriguez, Yadira Narvaez, Ralph Tuthill, MD, Brian Bolwell, MD, Jaroslaw Maciejewski, MD/PhD

Blood (2005) 106 (11): 597.

https://doi.org/10.1182/blood.V106.11.597.597

Published: 2005

Journal Articles

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

Brian Bolwell, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Steven Andresen, DO, Lisa Rybicki, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Matt Kalaycio, M.D.

Blood (2005) 106 (11): 5482.

https://doi.org/10.1182/blood.V106.11.5482.5482

Published: 2005

Journal Articles

Pulmonary Mortality after High-Dose Oral Busulfan and Autologous Stem Cell Transplant (ASCT) in Patients with Non-Hodgkin Lymphoma (NHL).

Matt Kalaycio, MD, Brad Pohlman, MD, Lisa Rybicki, Ronald Sobecks, MD, Elizabeth Kuczkowski, Steven Andresen, DO, Stacey Brown, Brian Bolwell, MD

Blood (2005) 106 (11): 1764.

https://doi.org/10.1182/blood.V106.11.1764.1764

Published: 2005

Journal Articles

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Brian Bolwell, MD, Linda McLellan, LISW, Larry Foster, Ph.D, Lisa Rybicki, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Mary Serafin, R.N., Karen Sands, R.N., Jennifer Kosar, R.N., Stacey Brown, Jennifer Bates, Mikkael Sekeres, MD, MS, Jane Dabney, LISW, Erin Welsh, LSW, Matt Kalaycio, MD

Blood (2005) 106 (11): 1322.

https://doi.org/10.1182/blood.V106.11.1322.1322

Published: 2005

NARROW

Intrathecal Chemotherapy Prophylaxis for CNS Relapse of DLBCL In the RCHOP Era: A Single Center Analysis.

High Rate of Survival in Transformed Lymphoma after Autologous Stem Cell Transplant (ASCT): Pathologic Analysis and Comparison with De Novo DLBCL.

Impact on Pulmonary Function of Pre-Transplant Radiotherapy in Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplant (ASCT).

Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation.

Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation.

Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant.

Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.

Long Term Follow Up with Etoposide Priming in Patients with Lymphoma.

Elevated Pretransplant Serum Ferritin in Autologous Stem Cell Transplant.

Pre-Transplant Biomarkers Predict GVHD and Treatment-Related Mortality in Patients Treated with Extracorporeal Photopheresis Prior to Allogeneic Bone Marrow Transplantation.

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML).

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Severe Mucositis Adversely Affects Survival after Autologous Stem Cell Transplantation (ABMT) for Lymphoid Malignancies.

Molecular Identification of Alloreactive CTL Precursors in Hematopoietic Stem Cell Transplantation.

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

Pulmonary Mortality after High-Dose Oral Busulfan and Autologous Stem Cell Transplant (ASCT) in Patients with Non-Hodgkin Lymphoma (NHL).

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only